| Basics |
Alphatec Holdings, Inc.
Alphatec Holdings Inc is a medical technology company. It is engaged in the design, development and promotion of products for the surgical treatment of spine disorders. Its product portfolio includes Biolocs, cervical, interbody, and others.
|
| IPO Date: |
June 2, 2006 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$3.19B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.16 | 3.03%
|
| Avg Daily Range (30 D): |
$0.34 | 1.70%
|
| Avg Daily Range (90 D): |
$0.30 | 1.89%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.45M |
| Avg Daily Volume (30 D): |
2.21M |
| Avg Daily Volume (90 D): |
2.03M |
| Trade Size |
| Avg Trade Size (Sh.): |
116 |
| Avg Trade Size (Sh.) (30 D): |
80 |
| Avg Trade Size (Sh.) (90 D): |
83 |
| Institutional Trades |
| Total Inst.Trades: |
2,523 |
| Avg Inst. Trade: |
$1.8M |
| Avg Inst. Trade (30 D): |
$2.91M |
| Avg Inst. Trade (90 D): |
$2.88M |
| Avg Inst. Trade Volume: |
.14M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.04M |
| Avg Closing Trade (30 D): |
$5.02M |
| Avg Closing Trade (90 D): |
$4.81M |
| Avg Closing Volume: |
166.1K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-1.04
|
$-.19
|
$-.27
|
|
Diluted EPS
|
$-1.04
|
$-.19
|
$-.27
|
|
Revenue
|
$ 728.02M
|
$ 196.5M
|
$ 185.54M
|
|
Gross Profit
|
$ 503.99M
|
$ 137.3M
|
$ 129.1M
|
|
Net Income / Loss
|
$ -154.96M
|
$ -28.58M
|
$ -41.14M
|
|
Operating Income / Loss
|
$ -97.13M
|
$ -15.93M
|
$ -13.09M
|
|
Cost of Revenue
|
$ 224.04M
|
$ 59.2M
|
$ 56.44M
|
|
Net Cash Flow
|
$ 74.1M
|
$ -1.16M
|
$ 3.74M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Aug 25, 2016:
1:12
|
|
|
|
